Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Carfostin by Asklepios BioPharmaceutical for Congestive Heart Failure (Heart Failure): Likelihood of Approval
Carfostin is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Congestive Heart Failure (Heart Failure). According...
Data Insights
Carfostin by Asklepios BioPharmaceutical for Congestive Heart Failure (Heart Failure): Likelihood of Approval
Carfostin is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Congestive Heart Failure (Heart Failure). According...